simian immunodeficiency virus (SIV)
GPTKB entity
Statements (50)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:virus
|
| gptkbp:bfsLayer |
4
|
| gptkbp:bfsParent |
gptkb:HIV
|
| gptkbp:affects |
monkeys
apes |
| gptkbp:associated_with |
biodiversity
conservation efforts endangered species public health concerns zoonotic diseases |
| gptkbp:caused_by |
simian AIDS
|
| gptkbp:communication |
sexual contact
mother to child contaminated needles |
| gptkbp:discovered_by |
gptkb:1980s
|
| https://www.w3.org/2000/01/rdf-schema#label |
simian immunodeficiency virus (SIV)
|
| gptkbp:impact |
ecosystems
human health animal health research funding wildlife populations |
| gptkbp:is_found_in |
primates
|
| gptkbp:is_protected_by |
safe sex practices
screening of blood products |
| gptkbp:is_similar_to |
gptkb:HIV-1
gptkb:HIV-2 |
| gptkbp:is_studied_in |
field studies
clinical trials laboratories non-human primates |
| gptkbp:origin |
SIV in African primates
|
| gptkbp:related_to |
gptkb:HIV
|
| gptkbp:research |
vaccine development
|
| gptkbp:research_focus |
immune response
treatment strategies viral load pathogenesis transmission dynamics |
| gptkbp:social_responsibility |
blood tests
|
| gptkbp:symptoms |
weight loss
fever diarrhea immunodeficiency opportunistic infections |
| gptkbp:transmission |
through bodily fluids
|
| gptkbp:treatment |
gptkb:drug
|
| gptkbp:type_of |
SI Vagm
SI Vcpz SI Vmac SI Vsyk |